T-CELL LEUKEMIA/LYMPHOMA, ADULT
Clinical trials for T-CELL LEUKEMIA/LYMPHOMA, ADULT explained in plain language.
Never miss a new study
Get alerted when new T-CELL LEUKEMIA/LYMPHOMA, ADULT trials appear
Sign up with your email to follow new studies for T-CELL LEUKEMIA/LYMPHOMA, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breakthrough trial aims to stop rare leukemia before it starts
Prevention Recruiting nowThis study tests whether the drug mogamulizumab can prevent adult T-cell leukemia/lymphoma (ATL) in people infected with HTLV-1 who have early warning signs in their T-cells. About 134 participants will receive a limited course of the drug to lower their viral load. The goal is t…
Matched conditions: T-CELL LEUKEMIA/LYMPHOMA, ADULT
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Jun 16, 2026 12:49 UTC
-
Scientists target cancer's weak spot: oxygen balance
Knowledge-focused Recruiting nowThis study looks for better ways to treat T-cell leukemia and lymphoma, a type of blood cancer. Researchers will test combinations of drugs that affect how cells handle oxygen-related stress, aiming to kill cancer cells while sparing healthy ones. The study involves 120 adults an…
Matched conditions: T-CELL LEUKEMIA/LYMPHOMA, ADULT
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:07 UTC